Celldex Launches Phase 2 Study Of Barzolvolimab For Atopic Dermatitis, Targeting Mast Cell-Driven Inflammation And Epithelial Barrier Dysfunction With Patient Enrollment Underway
Celldex Launches Phase 2 Study Of Barzolvolimab For Atopic Dermatitis, Targeting Mast Cell-Driven Inflammation And Epithelial Barrier Dysfunction With Patient Enrollment Underway
Celldex启动了巴佐洛单抗治疗特应性皮炎的第二阶段研究，旨在针对肥大细胞驱动的炎症和上皮屏障功能障碍，目前正在进行患者招募。
Celldex Launches Phase 2 Study Of Barzolvolimab For Atopic Dermatitis, Targeting Mast Cell-Driven Inflammation And Epithelial Barrier Dysfunction With Patient Enrollment Underway
Celldex启动了巴佐洛单抗治疗特应性皮炎的第二阶段研究，旨在针对肥大细胞驱动的炎症和上皮屏障功能障碍，目前正在进行患者招募。
资讯热榜
更新时间